A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis

NCT01840605 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis
Atopic

Interventions

DRUG: Bepotastine besilate
DRUG: ketotifen fumarate

Sponsor

Tanabe Pharma Corporation